GC Pharma

Search
Keyword Search
Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit
Product Search
close
Total Menu KOR
close

About usLeaders

huh,il sup huh,il sup
CHAIRMAN & CEO
HUH,
IL SUP
APPOINTED
September 1, 2009
CHAIRMANSHIP
Nomination &
Governance Committee

Since Mr. Huh became the company’s new CEO and chairman, GC Pharma (formerly known as Green Cross Corporation) has significantly expanded its global presence, setting up GCNA in the United States to oversee the North American market, GCBT in Canada to produce plasma-derived products, and GCAM to collect plasma needed for GCBT. GC Pharma now exports 12 plasma-derived products to over 50 countries. Mr. Huh, who holds a doctorate in management from the University of Houston, Texas, worked at Hanil Cement Industries prior to joining GC Pharma as a senior director in 1991, and has played a major role in the company’s dramatic growth for over the past two decades. Mr. Huh maintains an active presence outside the company as well, as chairman of the S.Korea Pharmaceutical Manufacturers Association and Vice-President of the S.Korea Biotechnology Industry Organization. Mr. Huh’s contributions and achievements have been recognized on numerous occasions, including receiving the Person of the Year Award at the Fourth Bio Spectrum Awards in 2012 and the Grand Prize in Health at the Proud Koreans Awards in 2013.

huh,il sup huh,il sup
PRESIDENT
HUH,
EUN CHUL
APPOINTED
September 1, 2015
CHAIRMANSHIP
Nomination &
Governance Committee

After earning a doctorate in food engineering from Cornell University, Mr. Huh joined GC Pharma, first as a researcher at the Mogam Biotechnology Institute, and then in the R&D Planning Office. Since his promotion to Chief Technology Officer (CTO) in 2009, Mr. Huh has acquired extensive experience and expertise in management and R&D. Since becoming one of the presidents at GC Pharma in 2015, Mr. Huh has overseen steady growth in company revenue in both the domestic and international markets, as well as strengthened GC Pharma’s corporate investment strategy and R&D abilities.

huh,yong jun huh,yong jun
EXECUTIVE VICE PRESIDENT
HUH,
YONG JUN
APPOINTED
March 24, 2017
CHAIRMANSHIP
Nomination &
Governance Committee

Appointed as President of GC (formerly known as Green Cross Holdings Corporation: It is a holding company for enhancing the specialization and competitiveness of Green Cross on the global market.) in 2017, Mr. Huh has held manager positions since obtaining his master’s degree from the University of Wisconsin. After his MBA program, Mr. Huh joined GC Pharma and worked in several capacities across the GC Group: as Vice-Secretary General at GC China in 2006, as Vice-President of GC in 2010, and as President and CEO of GC Wellbeing. Now an executive leader of GC, the parent company for all member companies of the GC Group, Mr. Huh continues to develop innovative strategies for taking GC Pharma to the next level and enhancing management in member companies.